Dow Up 0.07% Nasdaq Up 0.61%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
0.92 Down 0.00(0.29%) 4:00PM EST
Prev Close:0.92
Open:0.92
Bid:N/A
Ask:0.99 x 1400
1y Target Est:1.67
Beta:0.79
Next Earnings Date:N/A
Day's Range:0.91 - 0.93
52wk Range:0.85 - 2.20
Volume:45,254
Avg Vol (3m):235,243
Market Cap:47.63M
P/E (ttm):N/A
EPS (ttm):-1.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEODown 0.29%47.63M
AMGNUp 1.53%125.30B
PFEUp 2.07%195.95B
RHHBYUp 0.54%254.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.98
Quarterly EPS Est (Dec-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback